PURPOSE: Despite continual efforts to develop a prognostic model of gastric cancer by using clinical and pathologic parameters, a clinical test that can discriminate patients with good outcomes from those with poor outcomes after gastric cancer surgery has not been established. We aim to develop practical biomarker-based risk score that can predict relapse of gastric cancer after surgical treatment. EXPERIMENTAL DESIGN: Microarray technologies were used to generate and analyze gene expression profiling data from 65 gastric cancer patients to identify biomarker genes associated with relapse. The association of expression patterns of identified genes with relapse and overall survival was validated in independent gastric cancer patients. RESULTS: We uncovered two subgroups of gastric cancer that were strongly associated with the prognosis. For the easy translation of our findings into practice, we developed a scoring system based on the expression of six genes that predicted the likelihood of relapse after curative resection. In multivariate analysis, the risk score was an independent predictor of relapse in a cohort of 96 patients. We were able to validate the robustness of the six-gene signature in an additional independent cohort. CONCLUSIONS: The risk score derived from the six-gene set successfully prognosticated the relapse of gastric cancer patients after gastrectomy.
PURPOSE: Despite continual efforts to develop a prognostic model of gastric cancer by using clinical and pathologic parameters, a clinical test that can discriminate patients with good outcomes from those with poor outcomes after gastric cancer surgery has not been established. We aim to develop practical biomarker-based risk score that can predict relapse of gastric cancer after surgical treatment. EXPERIMENTAL DESIGN: Microarray technologies were used to generate and analyze gene expression profiling data from 65 gastric cancerpatients to identify biomarker genes associated with relapse. The association of expression patterns of identified genes with relapse and overall survival was validated in independent gastric cancerpatients. RESULTS: We uncovered two subgroups of gastric cancer that were strongly associated with the prognosis. For the easy translation of our findings into practice, we developed a scoring system based on the expression of six genes that predicted the likelihood of relapse after curative resection. In multivariate analysis, the risk score was an independent predictor of relapse in a cohort of 96 patients. We were able to validate the robustness of the six-gene signature in an additional independent cohort. CONCLUSIONS: The risk score derived from the six-gene set successfully prognosticated the relapse of gastric cancerpatients after gastrectomy.
Authors: Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend Journal: Nature Date: 2002-01-31 Impact factor: 49.962
Authors: Samuel Myllykangas; Siina Junnila; Arto Kokkola; Reija Autio; Ilari Scheinin; Tuula Kiviluoto; Marja-Liisa Karjalainen-Lindsberg; Jaakko Hollmén; Sakari Knuutila; Pauli Puolakkainen; Outi Monni Journal: Int J Cancer Date: 2008-08-15 Impact factor: 7.396
Authors: Su Ting Tay; Siew Hong Leong; Kun Yu; Amit Aggarwal; Soo Yong Tan; Chee How Lee; Keith Wong; Jaya Visvanathan; Dennis Lim; Wai Keong Wong; Khee Chee Soo; Oi Lian Kon; Patrick Tan Journal: Cancer Res Date: 2003-06-15 Impact factor: 12.701
Authors: Filipe Pinto; Nathalia C Campanella; Lucas F Abrahão-Machado; Cristovam Scapulatempo-Neto; Antonio T de Oliveira; Maria J Brito; Raquel P Andrade; Denise P Guimarães; Rui M Reis Journal: Gastric Cancer Date: 2015-05-21 Impact factor: 7.370
Authors: J Bargiela-Iparraguirre; L Prado-Marchal; N Pajuelo-Lozano; B Jiménez; R Perona; I Sánchez-Pérez Journal: Cell Cycle Date: 2014 Impact factor: 4.534